Monthly Archives: August 2017

Eric Lefkosky And Tempus: Revolutionizing Cancer Care

Published / by healthadmin

Almost everyone in the United States knows someone whose life has been touched by cancer. Even with the breakthrough in decoding the human gnome, processing the mountains of data and medical records to find the most effective treatment for each patient has presented a logistical nightmare. Fortunately, Eric Lefkofsky and Tempus, the company he co-founded, has been able to help. They created software that’s made a significant contribution towards improving data-enabled precision medicine. The company’s software reduces the processing time for electronic health records and hand-written doctors’ progress notes.

The technology Tempus created has streamlined the process of making effective use of the vast amount of data physicians treating cancer patients must consider by digitizing it. The Tempus platform quickly analyzes clinical and molecular data. This has transformed the delivery of cancer care. It has also helped make clinical and medical data more accessible and affordable. The Tempus technology, with its optical character recognition capabilities and natural language processing, turns the information into easily accessed structured data to improve cancer care and treatment and learn more about Eric.

Today, researchers fight cancer on the cellular and molecular level. Being able to quickly and easily combine genetic, molecular and clinical information on each patient allows for more effective cancer treatment. The Tempus technology enables researchers to find and unlock the hidden secrets to fighting cancer and other diseases and more accurately determine which treatments are more likely to work through the use of data-enabled precision medicine and more information click here.

A native of Southfield, Michigan, Eric Lefkofsky is a University of Michigan, Ann Arbor graduate. He also has a University of Michigan Law School Juris Doctor degree. Since graduating in 1993, Lefkofsky moved to Chicago and has founded or co-founded about a dozen very successful companies. Tempus is one of them. The headquarters of Tempus is in the Chicago area and Eric’s lacrosse camp.

Eric Lefkofsky is very active in the Chicago business community. He’s on the board of the Art Institute of Chicago, Lurie’s Children’s Memorial Hospital and the Chicago-based Steppenwolf Theatre Company. Lefkofsky has also taught at the business schools of DePaul University, Northwestern University and the University of Chicago.

More Visit: https://www.insidephilanthropy.com/guide-to-individual-donors/eric-lefkofsky.html

Allow Me To Re-Introduce Amicus Therapeutics

Published / by healthadmin

Amicus Therapeutics is a world wide biotechnology company based in Cranbury, New Jersey that was founded on February 4, 2002. It is on the cutting edge of advanced therapies and strategies for treating a wide array of annihilative rare and orphan diseases.

 

What particular diseases does Amicus Therapeutics focus on?

Amicus Therapeutics takes aim at a group of disorders that are collectively identified as lysosomal storage diseases (LSD).

 

What exactly are lysosomal storage diseases (LSD)?

An array of approximately 50 unique metabolic disorders that are inherited and are a result of imperfections found within the lysosomal function. Sacs of enzymes called lysosomes exists within cells that digest large molecules and then transfer the remnants on to other sections of the cell for reuse. The procedure needs several important enzymes and if any of these enzymes are defective due to mutation the larger molecules gather inside of the cell and eventually eradicate it.

 

What is CHART® and how does it work?

Chaperone-Advanced Replacement Therapy is Amicus Therapeutics’ main produce aimed at the development of enzyme replacement therapies.

 

Amicus Therapeutics VS Fabry

Amicus Therapeutics most promising candidate for the fight against Fabry is their product migalastat. It is a pharmacological chaperone treatment that targets the stabilization of endogenous mutant alpha-galactosidase along with the progression of migalastat monotherapy. They formed up in conjunction with JCR and Glaxo-SmithKline for three years (2010 to 2013) as the team analyzed the co-formulation with recombinant alpha-galactosidase (JR-051).

 

Expansion of Amicus Therapeutics

In 2008 Amicus Therapeutics expanded from one site located in New Jersey to open another facility in San Diego (http://www.marketwatch.com/investing/stock/fold).

In 2010 The Michael J. Fox Foundation blessed Amicus Therapeutics with a $500,000 grant so they could continue their studies in conjunction with the David Geffen School of Medicine at UCLA. In the same year, they received $210,300 grant that came from the Alzheimer’s Drug Discovery Foundation and the Alzheimer’s Disease Research Center at Mount Sinai.

 

Acquiring Competitors

2013 Callidus Biopharma

2015 Scioderm

 

Definitely, a company to keep your eye on Amicus Therapeutics offers a broad spectrum of treatment options for those suffering from human genetic diseases (Yahoo).

 

How Dr. Avi Weisfogel has Advanced Research for Sleep Apnea

Published / by healthadmin

Dr. Avi Weisfogel, the founder of Dental Sleep Masters, is onto something. His research on sleep apnea has led him into a new realm of possibilities for helping his patients feel better and live better lives. His way of doing so involves the creation of oral devices for sleep apnea treatment. One of his primary goals is to diagnose sleep apnea and treat it effectively. New research on this condition reveals that it can be related to more serious health conditions like diabetes and even stroke. The nature of this condition has often been downplayed as only a sleep issue, but with the new research we now know otherwise.

Dr. Weisfogel‘s dental background is extensive because of his dental career, however his dedication to learning more about sleep disorders like sleep apnea have given him the opportunity to help more patients. Additionally, Dr. Weisfogel’s focus was not just helping patients within his own practice, but he was aiming to train other dentists like himself to help more of their patients as well. Sleep apnea has gotten a lot of attention in years past, but because the number of cases has increased, Dr. Weisfogel now sees that many dentists are considering dedicating a larger portion of their practice to helping patients overcome sleep apnea.

Dental Sleep Masters was founded for the purpose of bringing more attention to this health condition, but what Dr. Weisfogel has created is actually a new model in sleep study. This endeavor is focused on involving the primary care physician as well as those who are considered secondary care. When care comes to a clinical level, this means that devices come into play. This is where Dr. Weisfogel can begin to help patients take more control of their sleep apnea and live with greater peace of mind knowing that an easier solution is just around the corner.

The days of CPAP machines may be over if Dr. Weisfogel’s training and oral devices continue to have a greater impact on those doctors that study sleep.

Why Buy Beneful at Walmart

Published / by healthadmin

Walmart sells such a vast number of products it can be overwhelming to shop others and many people will buy certain products at different specialty stores instead. In the case of buying dog food from a top brand like Beneful, Walmart is a great option.

Beneful is a great dog food to buy both because it has a scientifically designed to provide full nutrition for your dog and it is widely distributed all around the world which makes it easy to obtain. It also has a great history of being safe for dogs to consume and is a trusted brand by dog owners.

Walmart is about convenience and providing options for customers. Walmart carries a full line of Beneful dog food at affordable prices that are lower than their peers. Coupons and discounts from Walmart lower prices even further so stop by and find the right Beneful dog food for your dog today.

Insightful Facts You Need to Know about Jose Borghi

Published / by healthadmin

Jose Borghi was born in Presidente Prudente and schooled at PUC Campinus where he graduated with a degree in advertising. His success story began with many doubts not knowing what to pursue. After consulting his sister, she later invited him to view a performance at Castro Neves theater. The performance would later inspire him to be more focused on his interests which he eventually ventured. Apart from his first job at Ogilvy, he has worked in many other enterprises including Talent, DDB and Leo Burnett where he served as the president of the company as well as the vice chairperson of the creation of the prolific company. His business is viewed to be one of the most prolific advertising platforms by many individuals, and through his medium, Jose has helped to create a highly productive campaigns like mammals Parmalat. Through his creativity, the advert consisted of adorable children singing musical jingles to advertise a product for a company, and the ad is still known until today and read full article.

Besides, Jose Borghi is the Co-chief executive officer of Mullen love and is a very prolific leader of a promotional organization in the Brazilian market. Lowe began his professional career at notable standard Ogilvy group where he learned many skills in business and entrepreneurship. He worked together with his partner Erh Ray who helped and encouraged him to be persistent in his ventures. His positive attitude saw him put great effort and focus towards accomplishing all his goals, and as a result, the two entrepreneurs experienced a major success in their ventures. Jose was also very successful in his venture at Ogilvy group, and this marked the beginning of his great success in the field of entrepreneurship and Jose on Facebook.

The entrepreneur worked in collaboration with Ray and together they launched BorghiErh enterprise. The venture experienced a great success and attracted a lot of attention from many people in the early 2000`s. The two later changed the name of the enterprise to Borghe Lowe. The business then marked yet another great success for the two entrepreneurs through the remarkable sales and success that it made. Borghe Lowe has turned out to be so prolific and is highly recognized as well as celebrated by many people both locally and internationally. Later, the company updated its name to Mullen Lowe Brazil after merging with the prolific venture Mullen. Jose currently enjoys the great success of the enterprise together with the Co-Chief Executive officer of Andre Gomes.

More Visit: https://www.crunchbase.com/person/jose-henrique-borghi#/entity